    William Febbo | Merriman Curhan Ford & Co. | ZoomInfo.com
William J Febbo Profiles | Facebook

FacebookEmail or PhonePasswordForgot account?English (US)Espa√±olFran√ßais (France)‰∏≠Êñá(ÁÆÄ‰Ωì)ÿßŸÑÿπÿ±ÿ®Ÿäÿ©Portugu√™s (Brasil)ItalianoÌïúÍµ≠Ïñ¥Deutsch‡§π‡§ø‡§®‡•ç‡§¶‡•ÄÊó•Êú¨Ë™ûMessengerFacebook LitePeoplePlacesGamesLocationsCelebritiesMarketplaceGroupsRecipesMomentsInstagramAboutCreate AdCreate PageDevelopersCareersPrivacyCookiesAd ChoicesTermsSettingsActivity Log Facebook ¬© 2017


















 











¬†




William John Febbo - HERMOSA BEACH,CA | william febbo |CA| 4 People Finder Results





























People Finder.




Enter first name & last name





All States 
Alabama 
Alaska 
Arizona 
Arkansas 
California 
Colorado 
Connecticut 
Delaware 
Florida 
Georgia 
Hawaii 
Idaho 
Illinois 
Indiana 
Iowa 
Kansas 
Kentucky 
Louisiana 
Maine 
Maryland 
Massachusetts 
Michigan 
Minnesota 
Mississippi 
Missouri 
Montana 
Nebraska 
Nevada 
New Hampshire 
New Jersey 
New Mexico 
New York 
North Carolina 
North Dakota 
Ohio 
Oklahoma 
Oregon 
Pennsylvania 
Puerto Rico 
Rhode Island 
South Carolina 
South Dakota 
Tennessee 
Texas 
Utah 
Vermont 
Virginia 
Washington 
Washington D.C. 
West Virginia 
Wisconsin 
Wyoming 






People Finder Results for william febbo









Results from PublicRecords360.¬†Showing top 3 of 3 results.






Premium Public Records for William Febbo found in this find people section originate from public directories available on the internet to their subscribers. People Finder Results may contain information about Relatives & Classmates. If you are William Febbo and want to change or delete your or your relatives/ classmates record, please contact the data provider directly. InstantPeopleFinder.com caches the people finder results and after optout with the data provider, the results will automatically disappear after few days.



FullNameAddressesPhone
DOBRelativesMore Details
HERMOSA BEACH, CAWilliam John Febbo
3 Address(s) Found¬†Hermosa Beach,CARancho Santa Margarita,CACambridge,MA
6 Phone Number(s) Found¬†
Age: 78yrs.¬†¬†
Jackie FebboAlicia FebboDennis Febbo
Get Public Records, Property Records & more¬†¬†>>
SAN FRANCISCO, CAWilliam E Febbo
5 Address(s) Found¬†San Francisco,CACambridge,MABoston,MAJamaica Plain,MABirmingham,MI
9 Phone Number(s) Found¬†
Age: 48yrs.¬†¬†
Jennifer KoleanAlbert FebboPhillip FebboHelen Febbo
Get Public Records, Property Records & more¬†¬†>>
HERMOSA BEACH, CAWilliam J Febbo
3 Address(s) Found¬†Hermosa Beach,CAHawthorne,CALas Vegas,NV
2 Phone Number(s) Found¬†
¬†
Alicia FebboHelen Febbo
Get Public Records, Property Records & more¬†¬†>>

Results from Social Networks.¬†Showing top 1 of 1 results.






Social Networks Search Records related to the name William Febbo found in this find people section originate from public directories available on the internet to their subscribers. The data refers to public profiles on social networks such as Myspace, Facebook, LinkedIn and others. If you are William Febbo and want to change or delete an entry, please contact us as per our privacy policy. Also, if you are William Febbo and don't want to be related to the people finder results, please adjust your privacy settings with the respective network.



NameLocationScreen NameProfile LinkPostal AddressEmail AddressMore Details
William J. Febbo
San Francisco, CA1 Profile(s)-¬†
Get Social Report¬†¬†>>


Public Comments for william febbo.¬†






Public comments related to name William Febbo are submitted by users. You are solely responsible for your use of this section on InstantPeopleFinder.com and use them at your own risk. By using these forums and interactive areas, you agree not to post, transmit, distribute, store, create or otherwise publish any messages that violate our terms & conditions.




Leave a Public Comment for William Febbo





Please enable JavaScript to view the 
comments powered by Disqus.
blog
comments powered by Disqus





No Results Found.

Your people finder query - William Febbo in CA - did not yield any results.
Suggestions:

> Make sure search query is spelled correctly.
> Try a different search query.
> Try to be more general.

Or Try Intelius Premium People Finder:




First Name


Last Name (*)


State













Pages.


USA People Finder Search

Read Our Blog


News - Real Time People Search Tool ...


Privacy Policy




Terms & Conditions




Benefits of Service




How To Use




About Us



Contact Us




Follow us.


Become a fan and connect with ever-growing
community of People Finder Searchers. Share your thoughts and find out what Instant People Finder is up to next!














Find people with one click.

Find People information instantly! Easy to use, people finder for free using public
records, addresses, phone numbers, yellow pages and background check. From email
to address search or reverse phone number to a general people locator - we have
all the free people finder engine bases covered. So give it a try and get started
with the most basic surname search on free people finder page!










Browse. Name Directory by LastName.
abcdefghijklmnopqrstuvwxyz



Recent Updates.
Yesterday 07-26-2017 07-25-2017 07-24-2017 07-23-2017 07-22-2017 07-21-2017 



¬© Copyright & Trademark 2006-2017 InstantPeopleFinder.com - Instant People Finder. All rights reserved.
Instant People Finder Disclaimer for this Page: William John Febbo - HERMOSA BEACH,CA | william febbo |CA| 4 People Finder Results. Most records for people finder, search people free & background check for william febbo are dynamically obtained in real-time. Any private information consisting of email addresses, street addresses, phone numbers etc. for william febbo are gathered from an extensive list of free web sources available on major people search engines & social networks.


















William J Febbo - Hermosa Beach, CA | Intelius



























Sign In



We found William J Febbo in Hermosa Beach, CA


William J Febbo

                                                                           Intelius found that William J Febbo  is  a male between 100 and 110 years old from Hermosa Beach, CA.  We have connected them to
                3 addresses,
                2 phones,
                and 2 relatives or associates.
         






Get Report Now

Age

William J Febbo is in his 100s

William Has Lived In

Hermosa Beach, CA
Las Vegas, NV
Hawthorne, CA

William's Relatives

Alicia Febbo
Helen Febbo







William J Febbo



Zodiac SignCancer



GenderMale



Get Report Now










Want to know more about William? Get a comprehensive background report, find full phone numbers, and other contact information when available, all from billions of available public records.
            Continue below for more details about William, or use our people search engine to find others.
Get Background Check on William J Febbo
Get a Criminal Check on William J Febbo
Get a Public Record Report on William J Febbo
Get a People Search Report on William J Febbo


William J Febbo's Contact Information
Known Cities Lived In
Find out where William J Febbo has lived as well as William J Febbo's phone numbers and email addresses.




William J Febbo Has Lived in 2 States
California Address for William J Febbo


1426 B****** D* 

Hermosa Beach, CA


Has Lived In

Hermosa Beach, CA
Las Vegas, NV


Get Full Address Report










Phone Numbers Associated with William J Febbo

(310) ***-**** - Hawthorne, CA 
(310) ***-**** - Hermosa Beach, CA 


Get Full Phone Report



Email Addresses Associated with William J Febbo



Get Email Report




William J Febbo's Social Network and Potential Email Matches
Find out potential social network profiles and potential email usernamed for William J Febbo


William J Febbo's known Social Networks And Potential Email Matches

Find all of William J Febbo's Social Network Profiles

Get Full Report

Search Social Networks
Including Facebook, LinkedIn, MySpace, Google, Twitter, Yahoo, Jigsaw, ZoomInfo and more



Potential Email Matches
William Febbo
Username Matches

                  WilliamFebbo
                  FebboWilliam
                  William.Febbo
                  Febbo.William
                  William_Febbo
                  Febbo_William
                  William-Febbo
                  Febbo-William
                  WFebbo
               


Popular Email Services

@gmail.com
@aol.com
@yahoo.com
@comcast.net
@hotmail.com
@msn.com
@rocketmail.com
@att.net
@sbcglobal.net
@ymail.com
@facebook.com
@mail.com
@bellsouth.net
@live.com
@earthlink.net
@cox.net
@prodigy.net
@me.com
@peoplepc.com
@juno.com
@rediffmail.com
@mindspring.com
@comcast.com
@charter.net
@outlook.com




All trademarks, product names, company names or logos on this page are the property of their respective owners.
Related People Searches
W Febbo







         Intelius is a leading provider of public data about people and their connections to others. Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the Fair Credit Reporting Act (FCRA). This site should not be used to determine an individual‚Äôs eligibility for credit, insurance, employment, housing or any other purpose covered by the FCRA. For employment or tenant screening services, please visit our partner Talentwise.
      

About¬†Us
Site Map
About¬†Our¬†Reports
Blog
Help
Contact¬†Us

¬© 2003 ‚Äì 2017 PeopleConnect, Inc. d/b/a Intelius. All Rights Reserved.
         Privacy¬†Policy - UPDATED
Terms¬†of¬†Service - UPDATED






What is the FCRA?
The Fair Credit Reporting Act ("FCRA") is a federal law that promotes the accuracy, fairness and privacy of information in the files of consumer reporting agencies.
Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the FCRA. Intelius reports cannot be used for background checks related to consumer credit, insurance, employment, housing or any other purpose
                  prohibited under the FCRA.
You may not use any information obtained from Intelius for any purpose covered by the FCRA.
Find out more about the FCRA here.














OPRX William J. Febbo Insider Trades for OptimizeRx Corp.


































Bulletin






Investor Alert







New York Markets Close in:



Market Snapshot
Winners and Losers


















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































OptimizeRx Corp.

                  OTC: OPRX
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

OptimizeRx Corp.



Market open
¬†--Quotes are delayed by 20 min
Jul 28, 2017, 10:18 a.m.


OPRX

/quotes/zigman/4570908/delayed


$
1.06




Change

+0.01
+0.95%

Volume
Volume 3,600
Quotes are delayed by 20 min








/quotes/zigman/4570908/delayed
Previous close

$
			1.05
		


$
				1.06
			
Change

+0.01
+0.95%





Day low
Day high
$1.05
$1.06










52 week low
52 week high

            $0.63
        

            $1.19
        


















Insider Activity


Individual




William J. Febbo



Mr. Will J. Febbo is Chief Operating Officer at Merriman Capital, Inc., Chief Executive Officer at Panel Intelligence LLC, COO, CFO, Director & Head-Investor Relations at Merriman Holdings, Inc., and Treasurer at United Nations Association of Greater Boston. He is on the Board of Directors at Merriman Holdings, Inc.
Prior to Merriman Capital, Mr. Febbo founded and ran MedPanel LLC. He was employed as a Chairman by Pollone SA and a Principal by DURA Automotive Systems, Inc.
He received his BS in International Studies and Spanish from Dickinson College.



Transactions


Date
Shares
Transaction
Value





12/01/2016
4,000


¬†
Acquisition at $0.85 per share.


3,400


11/10/2016
9,000


¬†
Acquisition at $0.9 per share.


8,100


06/09/2016
11,567


¬†
Acquisition at $1.1 per share.


12,723


06/09/2016
10,000


¬†
Acquisition at $1.06 per share.


10,600





        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Mr. Gus D. Halas 
Chairman




Mr. William J. Febbo 
Chief Executive Officer & Director




Mr. Douglas Paul Baker 
CFO & Principal Accounting Officer




Mr. Brian J. Dillon 
Senior Vice President-Product & Strategy




Mr. Ed  Berger 
Senior Vice President-Marketing




Mr. Terence J. Hamilton 
Senior Vice President-Sales




Ms. Ellen O'Connor Vos 
Independent Director




Mr. James D. Lang 
Independent Director




Dr. Jack T. Pinney 
Independent Director









Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/65801738/composite TLT+1.11%


/quotes/zigman/59386294/composite JNUG-5.94%


X




Powered by














Log In




1:19 PM EDT
July 28, 2017


/marketstate/country/us
New York

	Open


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
¬†


/marketstate/country/uk
¬†


/marketstate/country/jp
¬†











View All



Latest News

/news/latest
1:16pAll the companies in Jeff Bezos‚Äôs empire, in one (large) chart
1:14pBaker Hughes data show weekly U.S. oil-rig count up a third time this month
1:13pAmazon‚Äôs post-earnings stock selloff is the smallest in seven years
1:13pEuropean stocks end at 3-month low as UBS falls, tech worries weigh 
1:11pSurging Australian dollar makes life tough for central bankers
1:10pU.S. weekly active oil-rig count up 2 at 766: Baker Hughes
1:10pU.S. total weekly active drilling-rig count up 8 at 958: Baker Hughes
1:10pSeptember WTI oil trades at $49.65/bbl little changed from before the rig data
1:09pWhy the SEC‚Äôs crackdown could be good for initial coin offerings
1:06pMattel shares down 8.7% in Friday trading
1:05pExpedia stock price target raised to $178 from $155 at UBS
1:05pAaron's shares up 13% in Friday trading
1:01pWhere health-care reform goes after failure to repeal and replace Obamacare
1:01pS&P 500 down 6 points, or 0.2%, at 2,470
1:00pDow industrials down 4 points at 21,792
12:59pBREAKINGNasdaq pares losses, down 5 points at 6,377
12:52pFTSE 100 closes sharply lower in tobacco-led stock rout
12:51pHere‚Äôs how much you should spend on a yoga mat (and why you should always use your own)
12:49pHow advisers can fight the ‚Äòcrisis of trust‚Äô in financial services
12:41pHow Venezuela chaos could spark oil rally OPEC has failed to achieve 
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,793.76

-2.79
-0.01%





nasdaq

/quotes/zigman/12633936/realtime
6,372.12

-10.06
-0.16%





s&p 500

/quotes/zigman/3870025/realtime
2,469.24

-6.18
-0.25%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				‚Ä¢ Trade your virtual portfolio in real time
				‚Ä¢ Talk strategies in group discussions
				‚Ä¢ Find or create a game that suits you
				‚Ä¢ Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
‚Ä¢ See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				‚Ä¢ How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright ¬© 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15
























































William J. Febbo: Executive Profile & Biography - Bloomberg









































  





















































































July 28, 2017 1:19 PM ET
Health Care Technology

Company Overview of OptimizeRx Corporation



SnapshotPeople¬†




OverviewBoard MembersCommittees



Executive Profile
William J. Febbo  Chief Executive Officer and Director, OptimizeRx CorporationAgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 4 different industries.See Board Relationships48$1,270,800As of Fiscal Year 2016
Background

		Mr. William J. Febbo, also known as Will, has been Chief Executive Officer of OptimizeRx Corporation since February 22, 2016 and serves as its Director. Mr. Febbo served as the Chief Executive Officer of Digital Capital Network at Merriman Holdings, Inc. Mr. Febbo served as Chairman and Founder of Plexuus, LLC. From 2013 to 2015, he also worked with Digital Capital Network, Inc., which operated a transaction platform for institutional and accredited investors. He served ... as Chief Executive Officer and Co-Founder and managed the day-to-day operations of the digital portal for institutional level investments at Digital Capital Network, Inc. Mr. Febbo served as Chief Executive Officer and co-founder of MedPanel, a provider of market intelligence and communications for the pharmaceutical, biomedical and medical device industries, which was eventually acquired by MCF Corporation. Mr. Febbo served as the Chief Operating Officer of Merriman Holdings, Inc. and Merriman Capital, Inc. since January 11, 2012 until August 11, 2015 and served as its Principal Financial Officer. He Co-founded MedPanel, LLC in 1999 and served as its Chief Executive Officer since April 17, 2007. Mr. Febbo served as Chief Executive Officer of MedPanel, LLC from January 1999 to April 2007. He has oversight of the Medpanel, Inc.'s sales, marketing, technology, finance and content development organizations, as well as expanding MedPanel's overseas activities. Mr. Febbo has been a Treasurer on the board of the United Nations of Greater Boston since November 2004. He is responsible for developing and overseeing the overall strategic direction of MedPanel and ensuring that the Medpanel, Inc. meets its quarterly and annual goals. He has more than 18 years experience in operations, sales, finance and manufacturing to the leadership of Panel Intelligence. Mr. Febbo has worked for three Fortune 500 companies, specializing in business development, merger and acquisition and global technology transfer in Europe, Central Asia and South America. From January 1996 to January 1999, he served at Dura Automotive working in business development and mergers and acquisition overseas. He served as the Chairman of Pollone from January 1998 to January 1999. Mr. Febbo holds several board and advisory roles in the biotech, clean tech and not-for-profit world. He has been a Director of Merriman Holdings, Inc. from April 2007 to February 17, 2016. He has been Director of MedPanel, LLC since April 2007. Mr. Febbo serves on the boards of the Carberry's, LLC. He served as a Director of Merriman Capital, Inc. until March 1, 2016. Mr. Febbo received a B.S. Degree in International Studies, with a focus on Economics and Spanish from Dickinson College.Read Full Background




Corporate Headquarters
400 Water StreetRochester, Michigan 48307United StatesPhone: 248-651-6568Fax: 248-453-5529
Board Members Memberships
Chief Executive Officer and DirectorOptimizeRx Corporation2007-PresentCo-Founder and Chairman MedPanel, LLC
Education
BS Dickinson College
Other Affiliations
Merriman Holdings, Inc.MedPanel, LLCDickinson CollegeMerriman Capital, Inc.


Annual Compensation
Salary$188,833Bonus$83,742Total Annual Compensation$272,575
Stocks Options
All Other Compensation$4,400Unexercisable Options$1,500,000Total Number of Options$1,500,000
Total Compensation
Total Annual Cash Compensation$276,975Total Short Term Compensation$272,575Other Long Term Compensation$4,400Total Calculated Compensation$1,270,800




Request Profile Update
















¬†












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



COMPETITOR COMPENSATIONThere is no Competitor Compensation data available.










Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
¬†|¬†
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact OptimizeRx Corporation, please visit .  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close


































































OptimizeRx Corp Appoints William J. Febbo as CEO | greyhealth group
















































    




LATEST NEWS




@GreyHealth







            OptimizeRx Corp Appoints William J. Febbo as CEO
       



 


            News
      
            2.22.2016
      



ROCHESTER, MI. ‚Äì February 22, 2016 ‚Äì OptimizeRx Corp. (OTCQB: OPRX), a software company whose premier content-delivery platform enables pharmaceutical companies to provide on-demand patient-savings and support services right at point of prescribe, has appointed William J. Febbo as chief executive officer. Febbo succeeds David Harrell, who will continue to serve as chairman of the Board.¬†
Febbo brings to OptimizeRx more than 18 years of experience in building and managing health services and financial businesses. His career includes strategic development, technology and product innovation, corporate finance, and M&A within a variety of leadership roles.¬†
‚ÄúWill‚Äôs extensive leadership experience in both technology and healthcare companies made him the ideal candidate to lead us through our next stage of growth,‚Äù said Harrell. ‚ÄúIn fact, he has already contributed important leadership when, as COO of Merriman Capital, he helped secure WPP's investment via their operating company, Grey Healthcare Group (GHG), a leading provider of healthcare communications services.‚Äù
Febbo commented: ‚ÄúWhen I met Dave and his team, it was clear they had the vision and passion to strengthen OptimizeRx‚Äôs market leadership in automating copay savings and product support right within physicians‚Äô electronic workflow. I helped lead the discussions for GHG to become a strategic investor, given their domain expertise, client reach, and strong leadership team. This team includes their CEO, Lynn Vos O‚ÄôConnor, who recently joined OptimizeRx‚Äôs board. Through this equity partnership, we plan to navigate OptimizeRx‚Äôs EHR eco-system and its unique pathway between medical professionals and industry to grow more brands and services.‚Äù
OptimizeRx has partnered with more than 20 of the largest pharmaceutical manufacturers in the world, including Pfizer, Lilly, Novartis, Sanofi, Bayer and AstraZeneca. These companies have automated their copay savings and trial voucher programs using OptimizeRx‚Äôs proprietary, on-demand, content delivery platform that reaches more than 250,000 healthcare providers through a network of over 350 electronic health records (EHRs).
OptimizeRx‚Äôs automation of copay savings for brand drugs as a replacement of traditional drug samples represents a total projected addressable market of more than $1 billion, with Surescripts forecast of more than 2 billion electronic prescriptions for 2016.
More and more pharmaceutical and biotech companies are seeking higher return on investment on their marketing by working with innovative digital platforms like OptimizeRx. The OptimizeRx platform has demonstrated an ROI of up to 12:1, according to independent studies sponsored by pharmaceutical companies. These companies recognize the need for new ways to reach and support doctors who have less and less time to spend with pharmaceutical sales representatives.
‚ÄúOur digital content-delivery platform is supporting the pharmaceutical industry‚Äôs shift from legacy paper prescription and sampling to a digitally enabled relationship between patient and medical provider,‚Äù continued Febbo. ‚ÄúBy connecting the fragmented EHR environment, we deliver streamlined information to physicians and measurably improve the patient experience. ¬†We provide innovative solutions to increase adherence to prescriptions, which represents a major obstacle to achieving improved health outcomes. OptimizeRx has the capital to expand its sales and marketing efforts, as well as launch new products and services to drive revenue growth.‚Äù
Lynn¬†O‚ÄôConnor Vos, OptimizeRx‚Äôs director and CEO of ghg, commented: ‚ÄúWill‚Äôs appointment comes at an opportune time with WPP and OptimizeRx developing new platforms to deliver vital information to physicians and patients. Together, we plan to expand OptimizeRx‚Äôs point-of-care EHR promotional network and service offerings.‚Äù
William J. Febbo Bio
Febbo is the founder and remains chairman of Plexuus, a payment processing platform for medical professionals with Sunshine Act-related activities.
Febbo was previously COO of Merriman Capital and CEO of Digital Capital Network (DCN), a wholly owned subsidiary of Merriman Holdings. He led the launch of DCN, a technology solution that increases transparency, compliance and efficiency for stakeholders.
Prior to Merriman, Febbo was CEO and co-founder of MedPanel, a provider of market intelligence and communications for the pharmaceutical, biomedical and medical device industries, which was eventually acquired by MCF Corporation. MedPanel completed over 3,000 engagements with the medical industry by engaging more than 300,000 medical professionals, allowing them to make better commercial and clinical decisions.
Febbo holds a Bachelor of Arts in International Studies from Dickinson College, in Pennsylvania.
About OptimizeRx Corporation
OptimizeRx¬†Corporation (OTCQB: OPRX) provides unique consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products, while offering pharmaceutical and healthcare companies effective ways to expand awareness, access and adherence to their medications.
The company‚Äôs core product, SampleMD‚Ñ¢, replaces drug samples with electronic trial vouchers and copay coupon savings, which are added to an e-Prescription and electronically sent to the pharmacy. SampleMD is integrated within leading Electronic Health Record (EHR) platforms, including Allscripts, Quest Diagnostics, Practice Fusion and Dr. First, reaching over 350 EHRs.
Important Cautions Regarding Forward Looking Statements
This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended and such section 21E of the Securities Act of 1934, amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
¬†











Share this:




Back





       



¬© 2017 GREYHEALTH GROUP.
          ALL RIGHTS RESERVED. PART OF WPP.

















Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on‚Ä¶ We‚Äôre sorry but this didn‚Äôt work.                  You can‚Äôt turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let‚Äôs get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser‚Äôs Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the ‚ÄúPersonalized ads in this browser‚Äù tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft‚Äôs privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show ‚Äúgeneric‚Äù ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show ‚Äúgeneric‚Äù ads, click Off.         If you choose ‚Äúgeneric‚Äù ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You‚Äôll still see ads, but they won‚Äôt be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
¬© 2017 Microsoft
















William J. Febbo | OptimizeRx






















 


 






(248) 651-6568 x 815
thamilton@optimizerx.com
 

Investors
  
 
 












Select Page


  
 



 



 








People
 
 
 
 



< back
 
 
 
 



William J. Febbo
Chief Executive Officer (CEO) and Director
Connecting the Pharma & Healthcare industry with compliant innovation has been Febbo‚Äôs trademark in over 18 years of leading health service & technology companies. In 1999, he co-founded MedPanel, a market intelligence and communication provider to the biomedical & medical device industries. When Febbo sold it in 2007 to Merriman Capital, he held dual roles as COO of the bank and CEO of Digital Capital Network which he launched pioneering digital compliance & transparency in the financial industry. 
Febbo is also founder of Plexuus, an early stage payment processing platform for medical professionals with Sunshine Act-related activities. Currently, he holds the position of CEO at OptimizeRX and continues to discover, innovate and connect both products and people to meaningful experiences to improve health outcomes. Febbo has most recently joined MIT linQ as a faculty member. LinQ is a new collaborative initiative focused on increasing the potential of innovative research to benefit society and the economy. linQ‚Äôs portfolio of international innovation programs demonstrates a new paradigm for technology research and training.  Thus far, Febbo has participated in two of these programs, IMPACT and Idea2 global. 
Febbo holds a Bachelor of Arts in International Studies from Dickinson College, in Pennsylvania and serves on the board of The United Nations of Greater Boston, a non-profit focused on building global citizens within inner-city schools in Massachusetts.
 
 

OptimizeRx Capabilities
For an overview of our capabilities, to demo our product, or to arrange a meeting with one of our account representatives.


			 
Contact us

 
 
 






Next
Brian Dillon¬†>

 
 
 
 
 
 






Services
						

Find the specific services now available from OptimizeRx.


					
 
 
Learn more

 




Partners
						

Explore the many benefits of partnering with OptimizeRx.


					
 
 
Learn more

 




Resources
						

Count on us to help with the information and answers you need.


					
 
 
Learn more

 




Investors
						

Review everything from SEC filings to earnings calls.


					
 
 
Learn more

 
 
 
 
 


 
 
 
 
 
 
 

 
 
 










OptimizeRx Corporation Appoints William J. Febbo as CEOHomeMailFlickrTumblrNewsSportsFinanceCelebrityAnswersGroupsMobileMoreTry Yahoo Finance on Firefox¬†¬ªYahooSearchSearchSign inU.S. Markets close in 2 hrs 41 minsS&P 5002,469.21-6.21 (-0.25%)Dow 3021,794.17-2.38 (-0.01%)Nasdaq6,372.17-10.01 (-0.16%)Today's ChartsDon't get blindsided by Tesla's shiny new Model 3OptimizeRx Corporation Appoints William J. Febbo as CEOMarketwiredFebruary 22, 2016ReblogShareTweetShareROCHESTER, MI--(Marketwired - February 22, 2016) - ¬†OptimizeRx Corp. (OPRX), a software company whose premier content-delivery platform enables pharmaceutical companies to provide on-demand patient-savings and support services right at point of prescribe, has appointed William J. Febbo as chief executive officer. Febbo succeeds David Harrell, who will continue to serve as chairman of the Board.Febbo brings to OptimizeRx more than 18 years of experience in building and managing health services and financial businesses. His career includes strategic development, technology and product innovation, corporate finance, and M&A within a variety of leadership roles."Will's extensive leadership experience in both technology and healthcare companies made him the ideal candidate to lead us through our next stage of growth," said Harrell. "In fact, he has already contributed important leadership when, as COO of Merriman Capital, he helped secure WPP's investment via their operating company, greyhealth group (ghg), a leading provider of healthcare communications services."Febbo commented: "When I met Dave and his team, it was clear they had the vision and passion to strengthen OptimizeRx's market leadership in automating copay savings and product support right within physicians' electronic workflow. I helped lead the discussions for ghg to become a strategic investor, given their domain expertise, client reach, and strong leadership team. This team includes their CEO, Lynn Vos O'Connor, who recently joined OptimizeRx's board. Through this equity partnership, we plan to navigate OptimizeRx's EHR eco-system and its unique pathway between medical professionals and industry to grow more brands and services."OptimizeRx has partnered with more than 20 of the largest pharmaceutical manufacturers in the world, including Pfizer, Lilly, Novartis, Sanofi, Bayer and AstraZeneca. These companies have automated their copay savings and trial voucher programs using OptimizeRx's proprietary, on-demand, content delivery platform that reaches more than 250,000 healthcare providers through a network of over 350 electronic health records (EHRs).OptimizeRx's automation of copay savings for brand drugs as a replacement of traditional drug samples represents a total projected addressable market of more than $1 billion, with Surescripts forecast of more than 2 billion electronic prescriptions for 2016.More and more pharmaceutical and biotech companies are seeking higher return on investment on their marketing by working with innovative digital platforms like OptimizeRx. The OptimizeRx platform has demonstrated an ROI of up to 12:1, according to independent studies sponsored by pharmaceutical companies. These companies recognize the need for new ways to reach and support doctors who have less and less time to spend with pharmaceutical sales representatives."Our digital content-delivery platform is supporting the pharmaceutical industry's shift from legacy paper prescription and sampling to a digitally enabled relationship between patient and medical provider," continued Febbo. "By connecting the fragmented EHR environment, we deliver streamlined information to physicians and measurably improve the patient experience.¬†We provide innovative solutions to increase adherence to prescriptions, which represents a major obstacle to achieving improved health outcomes. OptimizeRx has the capital to expand its sales and marketing efforts, as well as launch new products and services to drive revenue growth."Lynn Vos O'Connor, OptimizeRx's director and CEO of ghg, commented: "Will's appointment comes at an opportune time with WPP and OptimizeRx developing new platforms to deliver vital information to physicians and patients. Together, we plan to expand OptimizeRx's point-of-care EHR promotional network and service offerings."William J. Febbo BioFebbo is the founder and remains chairman of Plexuus, a payment processing platform for medical professionals with Sunshine Act-related activities.Febbo was previously COO of Merriman Capital and CEO of Digital Capital Network (DCN), a wholly owned subsidiary of Merriman Holdings. He led the launch of DCN, a technology solution that increases transparency, compliance and efficiency for stakeholders.Read MorePrior to Merriman, Febbo was CEO and co-founder of MedPanel, a provider of market intelligence and communications for the pharmaceutical, biomedical and medical device industries, which was eventually acquired by MCF Corporation. MedPanel completed over 3,000 engagements with the medical industry by engaging more than 300,000 medical professionals, allowing them to make better commercial and clinical decisions.Febbo holds a Bachelor of Arts in International Studies from Dickinson College, in Pennsylvania.About OptimizeRx CorporationOptimizeRx¬†Corporation (OPRX) provides unique consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products, while offering pharmaceutical and healthcare companies effective ways to expand awareness, access and adherence to their medications.The company's core product, SampleMD‚Ñ¢, replaces drug samples with electronic trial vouchers and copay coupon savings, which are added to an e-Prescription and electronically sent to the pharmacy. SampleMD is integrated within leading Electronic Health Record (EHR) platforms, including Allscripts, Quest Diagnostics, Practice Fusion and Dr. First, reaching over 350 EHRs.Important Cautions Regarding Forward Looking StatementsThis press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended and such section 21E of the Securities Act of 1934, amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextShkreli portrayed both as liar, well-meaning as trial nears endReutersThis Will Be In Everyone's Household By 2020Banyan HillSponsoredHow fentanyl is making the opioid epidemic even worseVoxThe Senate probe into big pharma's hand in the opioid crisis just got biggerBusiness InsiderMartin Shkreli's lawyer says former drug company chairman tried to 'seduce' the 'pharma bro'CNBCEngineer Finds Pattern; Makes Millions in StocksMoney MorningSponsored'Pharma Bro' won't stop talking, except to jury in trialAssociated PressTax cuts just got more likelyYahoo FinanceThe 'two pizza rule' is a secret to productive meetings that helped Amazon CEO Jeff Bezos become one of the world's richest menBusiness InsiderZuckerberg Wife's Ambitious Secret Finally ExposedUNewz.MeSponsoredTODAY'S CHARTS: Don't get blindsided by Tesla's shiny new Model 3Yahoo FinanceWhy Apple is discontinuing these iPodsYahoo Finance VideoHow a one-of-a-kind business has kept 5,000 kitchens out of landfillsYahoo FinanceDiscover it: 4.8 out of 5 avg. by 24K+ customersDiscover CardSponsoredThe real reason overseas manufacturing is coming to AmericaYahoo FinanceTrump‚Äôs unwitting legacy could be universal health coverageYahoo FinanceTrump Is Acting Suspicious Because He ‚ÄòMay Be‚Äô Innocent, Fox News SaysBen: I always hire a slew of lawyers when I haven't done anything so it makes perfect sense. üòÇüòÇJoin the Conversation1 / 51.3k








